US biotech company Moderna ($MRNA) is talking with the Japanese health ministry about the supply of 40 million corona vaccines. The company confirmed this Friday afternoon after Japanese minister Kato Katsunobu communicated about this in national media.

The vaccine will be supplied by Moderna, while Takeda Pharmaceutical will be responsible for distribution. The company would supply the vaccines from the first half of 2021, if the vaccine gets regulatory approval.

Although FDA chief Stephen Hahn attempted to make the argument that the FDA will remain on the straight and narrow science road in approving vaccines for greater public use against the COVID-19 pandemic, President Trump set his own timetable and delivered the agency’s marching orders that would be hard pressed to follow. Earlier today Trump promised a safe and effective vaccine for COVID-19 before the end of 2020. It’s puts pressure on the farmaceutical industry with its effects on farmaceutical stocks like Moderna.

Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.